Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

YM 264 MeSH Supplementary Concept Data 2025


MeSH Supplementary
YM 264
Unique ID
C068679
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C068679
Entry Term(s)
1-(3-methyl-3-phenylbutyl)-4-(2-(3-pyridyl)thiazolidin-4-ylcarbonyl)piperazine fumarate
YM-264
Registry Numbers
131888-54-5
CAS Type 1 Name
Piperazine, 1-(3-methyl-3-phenylbutyl)-4-((2-(3-pyridinyl)-4-thiazolidinyl)carbonyl)-, (E)-2-butenedioate (1:1)
Previous Indexing
*THIAZOLES (1991-2006)
Heading Mapped to
*Piperazines
*Thiazolidines
Frequency
9
Note
PAF antagonist
Source
Biochem Biophys Res Commun 1991;176(2):781
Indexing Information
Platelet Activating Factor
Date of Entry
1991/05/31
Revision Date
2006/09/22
YM 264 Preferred
1-(3-methyl-3-phenylbutyl)-4-(2-(3-pyridyl)thiazolidin-4-ylcarbonyl)piperazine fumarate Broader
page delivered in 0.005s